MarketPulse

clinical trial misrepresentation

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Soleno Therapeutics Faces Class Action Over Undisclosed Drug Safety Issues

Soleno Therapeutics faces class action lawsuit over alleged failure to disclose safety issues with drug DCCR, following 12-27% stock declines from August-September 2025 revelations.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Soleno Therapeutics Faces Class Action Over DCCR Safety Claims as Stock Plummets

Soleno Therapeutics faces class action lawsuit over DCCR safety concealment claims, with investors suffering significant losses following critical short-seller report and patient death disclosure.
SLNOsecurities fraudclass action lawsuit